Delcath Systems Inc. (DCTH) NASDAQ
$4.83 (0.26) (-5.11%)
Market Cap: $125.02M
As of 03/28/24 02:38 PM EDT. Market open.
Delcath Systems Inc. (DCTH)
NASDAQ
$4.83
(0.26) (-5.11%)
Market Cap: $125.02M
As of 03/28/24 02:38 PM EDT. Market open.
delcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. delcath ... read more
delcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. delcath is in late-stage clinical development in the united states with initial commercial activities in europe, where the melphalan/hds is marketed as a ce marked device under the trade name delcath hepatic chemosat® delivery system for melphalan (chemosat). our commercial strategy for chemosat is to steadily grow clinical adoption in major european markets and utilize physician experience to support appeals for reimbursement. since launch over 250 chemosat treatments have been performed at over 20 leading european cancer centers. in 2016, we launched our focus pivotal study in hepatic dominant ocular read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Aharon Gil | Director | Mar 19, 2024 | Buy | $3.72 | 26,882 | 100,001 | 1,069,710 | Mar 20, 2024, 08:00 PM |
SALAMON STEVEN A J | Director | Mar 19, 2024 | Buy | $3.72 | 26,882 | 100,001 | 1,121,025 | Mar 20, 2024, 07:44 PM |
Vukovic Vojo | CHIEF MEDICAL OFFICER | Mar 19, 2024 | Option Exercise | $3.72 | 26,882 | 100,001 | 126,882 | Mar 19, 2024, 05:03 PM |
MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | Mar 19, 2024 | Option Exercise | $3.72 | 40,323 | 150,002 | 302,668 | Mar 19, 2024, 05:01 PM |
Pennell Sandra | SVP OF FINANCE, PFO AND PAO | Mar 19, 2024 | Option Exercise | $3.72 | 26,881 | 99,997 | 61,052 | Mar 19, 2024, 04:59 PM |
Muir Kevin | GM INTERVENTIONAL ONCOLOGY | Mar 19, 2024 | Option Exercise | $3.72 | 13,441 | 50,001 | 18,582 | Mar 19, 2024, 04:58 PM |
Hoffman David L. | GEN'L COUNSEL, CCO & SECY | Mar 19, 2024 | Option Exercise | $3.72 | 20,161 | 74,999 | 74,330 | Mar 19, 2024, 04:57 PM |
Vukovic Vojo | Chief Medical Officer | Dec 12, 2023 | Buy | $3.00 | 40,000 | 120,000 | 100,000 | Dec 14, 2023, 04:20 PM |
MICHEL GERARD J | Chief Executive Officer | Dec 08, 2023 | Buy | $2.94 | 34,000 | 99,960 | 262,345 | Dec 11, 2023, 05:02 PM |
Rosalind Advisors, Inc. | Director | Nov 17, 2023 | Buy | $2.40 | 100,000 | 240,410 | 1,038,828 | Nov 21, 2023, 11:07 AM |
Pennell Sandra | SVP of Finance, PFO and PAO | Nov 17, 2023 | Buy | $2.43 | 30,000 | 72,900 | 30,000 | Nov 21, 2023, 07:42 AM |
Vukovic Vojo | Chief Medical Officer | Nov 16, 2023 | Buy | $2.48 | 60,000 | 148,800 | 60,000 | Nov 20, 2023, 04:22 PM |
Hoffman David L. | See Remarks | Nov 16, 2023 | Buy | $2.48 | 40,000 | 99,200 | 40,000 | Nov 20, 2023, 04:20 PM |
Purpura John | Chief Operating Officer | Oct 13, 2023 | Buy | $3.44 | 14,505 | 49,897 | 41,526 | Oct 17, 2023, 04:53 PM |
Sylvester John Richard | Director | Aug 21, 2023 | Buy | $4.80 | 10,550 | 50,640 | 10,550 | Aug 23, 2023, 11:03 AM |
MICHEL GERARD J | Chief Executive Officer | Aug 18, 2023 | Option Exercise | $4.50 | 31,110 | 139,995 | 228,345 | Aug 21, 2023, 12:05 PM |
MICHEL GERARD J | Chief Executive Officer | Mar 29, 2023 | Buy | $4.84 | 19,646 | 95,087 | 197,235 | Mar 30, 2023, 09:00 AM |
Rosalind Advisors, Inc. | Director | Dec 14, 2022 | Buy | $3.62 | 15,215 | 55,045 | 459,315 | Dec 16, 2022, 09:32 AM |
SALAMON STEVEN A J | Director | Dec 14, 2022 | Buy | $3.62 | 15,215 | 55,045 | 455,315 | Dec 16, 2022, 09:22 AM |
MICHEL GERARD J | Chief Executive Officer | Dec 13, 2022 | Buy | $2.90 | 51,725 | 150,003 | 177,589 | Dec 14, 2022, 03:33 PM |
MICHEL GERARD J | Chief Executive Officer | Jul 20, 2022 | Buy | $3.98 | 62,814 | 250,000 | 125,864 | Jul 21, 2022, 10:29 AM |
Purpura John | Chief Operating Officer | May 16, 2022 | Buy | $4.61 | 3,300 | 15,213 | 27,021 | May 18, 2022, 10:42 AM |
SALAMON STEVEN A J | Director | May 13, 2022 | Buy | $5.03 | 5,000 | 25,135 | 440,100 | May 16, 2022, 12:04 PM |
SALAMON STEVEN A J | Director | May 12, 2022 | Buy | $4.90 | 6,000 | 29,424 | 29,424 | May 13, 2022, 12:12 PM |
Rosalind Advisors, Inc. | Director | Apr 19, 2022 | Buy | $6.25 | 1,600 | 10,000 | 433,100 | Apr 21, 2022, 12:42 PM |
SALAMON STEVEN A J | Director | Apr 19, 2022 | Buy | $6.25 | 1,600 | 10,000 | 429,100 | Apr 20, 2022, 03:47 PM |
Rosalind Advisors, Inc. | Director | Apr 18, 2022 | Buy | $6.35 | 2,000 | 12,697 | 431,500 | Apr 19, 2022, 01:52 PM |
Aharon Gil | Director | Apr 18, 2022 | Buy | $6.35 | 2,000 | 12,697 | 404,000 | Apr 19, 2022, 01:52 PM |
MICHEL GERARD J | See Remarks | Apr 18, 2022 | Buy | $6.37 | 2,000 | 12,734 | 63,050 | Apr 18, 2022, 09:23 PM |
Rosalind Advisors, Inc. | Director | Apr 13, 2022 | Buy | $6.45 | 1,500 | 9,675 | 429,500 | Apr 14, 2022, 05:20 PM |
SALAMON STEVEN A J | Director | Apr 13, 2022 | Buy | $6.45 | 1,500 | 9,675 | 427,500 | Apr 14, 2022, 01:47 PM |
Rosalind Advisors, Inc. | Director | Apr 12, 2022 | Buy | $6.48 | 2,500 | 16,200 | 428,000 | Apr 12, 2022, 06:42 PM |
SALAMON STEVEN A J | Director | Apr 12, 2022 | Buy | $6.48 | 2,500 | 16,200 | 425,000 | Apr 12, 2022, 05:58 PM |
Purpura John | Chief Operating Officer | Apr 11, 2022 | Buy | $6.59 | 5,000 | 32,950 | 23,721 | Apr 11, 2022, 04:11 PM |
MICHEL GERARD J | See Remarks | Apr 08, 2022 | Buy | $6.57 | 2,000 | 13,136 | 61,050 | Apr 08, 2022, 06:25 PM |
SALAMON STEVEN A J | Director | Apr 07, 2022 | Buy | $6.41 | 1,000 | 6,410 | 423,500 | Apr 08, 2022, 11:23 AM |
SALAMON STEVEN A J | Director | Apr 06, 2022 | Buy | $6.49 | 1,000 | 6,490 | 422,500 | Apr 08, 2022, 11:23 AM |
Rosalind Advisors, Inc. | Director | Apr 07, 2022 | Buy | $6.41 | 1,000 | 6,410 | 425,500 | Apr 08, 2022, 09:43 AM |
Rosalind Advisors, Inc. | Director | Apr 06, 2022 | Buy | $6.49 | 1,000 | 6,490 | 424,500 | Apr 08, 2022, 09:43 AM |
Purpura John | Chief Operating Officer | Nov 19, 2020 | Buy | $12.68 | 1,600 | 20,288 | 14,721 | Apr 05, 2022, 04:58 PM |
SALAMON STEVEN A J | Director | Dec 30, 2021 | Buy | $7.56 | 2,000 | 15,120 | 421,500 | Jan 03, 2022, 02:04 PM |
Rosalind Advisors, Inc. | Director | Dec 30, 2021 | Buy | $7.56 | 2,000 | 15,120 | 423,500 | Jan 03, 2022, 02:02 PM |
MICHEL GERARD J | See Remarks | Dec 02, 2021 | Buy | $8.61 | 23,200 | 199,752 | 59,050 | Dec 06, 2021, 06:06 PM |
SALAMON STEVEN A J | Director | Jun 30, 2021 | Buy | $12.76 | 5,500 | 70,180 | 419,500 | Jul 01, 2021, 10:47 AM |
Rosalind Advisors, Inc. | Director | Jun 30, 2021 | Buy | $12.76 | 5,500 | 70,180 | 421,500 | Jul 01, 2021, 10:45 AM |
Rosalind Advisors, Inc. | Director | Jun 28, 2021 | Buy | $11.56 | 5,000 | 57,800 | 416,000 | Jul 01, 2021, 10:44 AM |
SALAMON STEVEN A J | Director | Jun 28, 2021 | Buy | $11.56 | 5,000 | 57,800 | 414,000 | Jun 30, 2021, 09:53 AM |
Rosalind Advisors, Inc. | Director | Jun 28, 2021 | Buy | $11.56 | 500,000 | 5,780,000 | 416,000 | Jun 30, 2021, 09:52 AM |
MICHEL GERARD J | Chief Executive Officer | Jun 28, 2021 | Buy | $11.93 | 6,250 | 74,563 | 35,850 | Jun 29, 2021, 01:46 PM |
MICHEL GERARD J | Chief Executive Officer | Jun 25, 2021 | Buy | $11.35 | 6,600 | 74,910 | 29,600 | Jun 29, 2021, 01:46 PM |
SALAMON STEVEN A J | Director | Jun 24, 2021 | Buy | $10.90 | 4,500 | 49,050 | 409,000 | Jun 28, 2021, 08:50 AM |
Purpura John | Chief Operating Officer | May 13, 2021 | Buy | $9.42 | 4,000 | 37,680 | 18,713 | May 14, 2021, 08:06 AM |
SALAMON STEVEN A J | Director | Mar 31, 2021 | Option Exercise | $10.00 | 215,000 | 2,150,000 | 404,500 | Apr 01, 2021, 04:24 PM |
Rosalind Advisors, Inc. | Director | Mar 31, 2021 | Option Exercise | $10.00 | 215,000 | 2,150,000 | 406,500 | Apr 01, 2021, 04:23 PM |
Aharon Gil | Director | Mar 31, 2021 | Option Exercise | $10.00 | 215,000 | 2,150,000 | 402,000 | Apr 01, 2021, 04:22 PM |
MICHEL GERARD J | Chief Executive Officer | Dec 11, 2020 | Buy | $13.25 | 7,500 | 99,375 | 7,500 | Dec 14, 2020, 02:00 PM |
Purpura John | Chief Operating Officer | Nov 19, 2020 | Buy | $12.68 | 1,600 | 20,288 | 14,713 | Nov 20, 2020, 04:05 PM |
Rosalind Advisors, Inc. | Director | Nov 17, 2020 | Buy | $12.11 | 2,500 | 30,280 | 191,500 | Nov 19, 2020, 02:27 PM |
SALAMON STEVEN A J | Director | Nov 17, 2020 | Buy | $12.11 | 2,500 | 30,280 | 189,500 | Nov 17, 2020, 12:37 PM |
Rosalind Advisors, Inc. | Director | Nov 13, 2020 | Buy | $11.75 | 4,000 | 47,000 | 189,000 | Nov 16, 2020, 01:21 PM |
Aharon Gil | Director | Nov 16, 2020 | Buy | $12.00 | 2,000 | 24,000 | 187,000 | Nov 16, 2020, 01:20 PM |
SALAMON STEVEN A J | Director | Nov 13, 2020 | Buy | $11.51 | 2,000 | 23,020 | 187,000 | Nov 13, 2020, 01:43 PM |
Purpura John | EVP, Global Operations | Sep 28, 2018 | Buy | $1.75 | 5,500 | 9,625 | 5,501 | Oct 23, 2018, 04:20 PM |
STOLL ROGER G PHD | Director | Sep 28, 2018 | Buy | $1.75 | 4,900 | 8,575 | 5,901 | Oct 23, 2018, 04:19 PM |
Simpson Jennifer K. | President & CEO | Sep 28, 2018 | Buy | $1.75 | 7,399 | 12,948 | 7,500 | Oct 23, 2018, 04:16 PM |
Keck Barbra | Chief Financial Officer | Sep 28, 2018 | Buy | $1.75 | 7,399 | 12,948 | 7,500 | Oct 23, 2018, 04:16 PM |
Rueckert William Dodge | Director | Sep 28, 2018 | Buy | $1.75 | 6,500 | 11,375 | 7,926 | Oct 23, 2018, 04:16 PM |
STOLL ROGER G PHD | Director | Aug 01, 2018 | Buy | $2.47 | 1,000 | 2,466 | 1,001 | Aug 02, 2018, 09:25 PM |
Rueckert William Dodge | Director | Jul 31, 2018 | Buy | $2.53 | 3,208 | 8,103 | 3,209 | Aug 02, 2018, 09:06 PM |
Keck Barbra | Chief Financial Officer | Aug 01, 2018 | Buy | $2.39 | 100 | 239 | 101 | Aug 02, 2018, 07:17 PM |
Simpson Jennifer K. | President & CEO | Jul 31, 2018 | Buy | $2.55 | 100 | 255 | 101 | Aug 02, 2018, 07:01 PM |
Simpson Jennifer K. | President & CEO | Jun 27, 2017 | Option Exercise | $0.22 | 468 | 102 | 41,908 | Jun 29, 2017, 04:30 PM |
Purpura John | EVP, Regulatory Affairs | Jun 27, 2017 | Option Exercise | $0.22 | 230 | 50 | 35,398 | Jun 29, 2017, 04:30 PM |
Keck Barbra | Chief Financial Officer | Jun 27, 2017 | Option Exercise | $0.22 | 168 | 37 | 23,887 | Jun 29, 2017, 04:30 PM |
Keck Barbra | Senior VP, Finance | Jun 16, 2016 | Option Exercise | $0.25 | 8,561 | 2,140 | 64,926 | Jun 17, 2016, 04:04 PM |
Purpura John | EVP, Regulatory Affairs | Jun 16, 2016 | Option Exercise | $0.25 | 11,738 | 2,935 | 90,074 | Jun 17, 2016, 04:03 PM |
Simpson Jennifer K. | President & CEO | Jun 16, 2016 | Option Exercise | $0.25 | 24,004 | 6,001 | 178,292 | Jun 17, 2016, 04:03 PM |
STOLL ROGER G PHD | Director | Jul 27, 2015 | Buy | $0.54 | 20,000 | 10,740 | 99,145 | Jul 28, 2015, 05:05 PM |
Taglietti Marco | Director | Jul 28, 2015 | Buy | $0.54 | 100,000 | 54,433 | 220,000 | Jul 28, 2015, 03:50 PM |
Taglietti Marco | Director | Jul 27, 2015 | Buy | $0.52 | 100,000 | 52,350 | 120,000 | Jul 28, 2015, 03:50 PM |
Philips Laura A | Director | Jul 23, 2015 | Buy | $0.50 | 91,011 | 45,333 | 205,299 | Jul 24, 2015, 04:56 PM |
Philips Laura A | Director | Jul 22, 2015 | Buy | $0.49 | 71,642 | 35,376 | 114,288 | Jul 24, 2015, 04:56 PM |
Rueckert William Dodge | Director | Jul 22, 2015 | Buy | $0.48 | 20,000 | 9,580 | 40,000 | Jul 22, 2015, 05:54 PM |
LEUNG GABRIEL | Director | Jun 15, 2012 | Buy | $1.57 | 7,500 | 11,761 | 15,847 | Jun 18, 2012, 04:05 PM |
Philips Laura A | Director | Jun 01, 2012 | Buy | $1.51 | 65,000 | 98,049 | 130,854 | Jun 04, 2012, 05:31 PM |
WATSON DOUGLAS G | Director | Jun 01, 2012 | Buy | $1.51 | 50,000 | 75,275 | 61,369 | Jun 04, 2012, 05:23 PM |
Koplewicz Harold S | Director | Jun 01, 2012 | Buy | $1.49 | 66,667 | 99,454 | 148,521 | Jun 04, 2012, 04:56 PM |
Purpura John | EVP Reg. Affairs/Quality Assur | Jun 01, 2012 | Buy | $1.49 | 5,000 | 7,450 | 20,000 | Jun 04, 2012, 04:52 PM |
HOBBS EAMONN P | President and CEO | Jun 01, 2012 | Buy | $1.52 | 7,000 | 10,611 | 162,000 | Jun 04, 2012, 04:47 PM |
Simpson Jennifer K. | Exec. VP, Global Marketing | Jun 01, 2012 | Buy | $1.49 | 3,000 | 4,470 | 10,750 | Jun 04, 2012, 04:43 PM |
Miao Graham G | Exec. V.P., CFO | May 31, 2012 | Buy | $1.50 | 20,000 | 30,000 | 54,000 | Jun 04, 2012, 04:25 PM |
Kandarpa Krishna | Exec. V.P., Chief Medical Off. | Jan 06, 2012 | Sale | $3.75 | 34,606 | 129,790 | 150,000 | Jan 06, 2012, 04:57 PM |
LADD ROBERT | Director | Dec 22, 2011 | Sale | $2.44 | 10,000 | 24,421 | 641,294 | Dec 23, 2011, 05:50 PM |
LADD ROBERT | Director | Dec 23, 2011 | Sale | $2.47 | 10,000 | 24,660 | 631,294 | Dec 23, 2011, 05:50 PM |
LADD ROBERT | Director | Dec 21, 2011 | Sale | $2.00 | 10,000 | 20,000 | 651,294 | Dec 21, 2011, 05:35 PM |
LADD ROBERT | Director | Dec 20, 2011 | Sale | $1.95 | 10,000 | 19,500 | 661,294 | Dec 21, 2011, 05:35 PM |
LADD ROBERT | Director | Dec 19, 2011 | Sale | $1.92 | 10,000 | 19,185 | 671,294 | Dec 19, 2011, 06:20 PM |
LADD ROBERT | Director | Dec 16, 2011 | Sale | $1.96 | 10,000 | 19,614 | 681,294 | Dec 19, 2011, 06:20 PM |
LADD ROBERT | Director | Dec 15, 2011 | Sale | $2.01 | 10,000 | 20,114 | 691,294 | Dec 15, 2011, 05:37 PM |
LADD ROBERT | Director | Dec 14, 2011 | Sale | $2.09 | 10,000 | 20,900 | 701,294 | Dec 15, 2011, 05:37 PM |
LADD ROBERT | Director | Dec 13, 2011 | Sale | $2.28 | 10,000 | 22,800 | 711,294 | Dec 13, 2011, 09:11 PM |
LADD ROBERT | Director | Dec 12, 2011 | Sale | $2.30 | 10,000 | 23,000 | 721,294 | Dec 13, 2011, 09:11 PM |
Owner | Relationship | Date | Value($) |
Aharon Gil | Director | 03/19/2024 | 100,001 |
SALAMON STEVEN A J | Director | 03/19/2024 | 100,001 |
Vukovic Vojo | CHIEF MEDICAL OFFICER | 03/19/2024 | 100,001 |
MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | 03/19/2024 | 150,002 |
Pennell Sandra | SVP OF FINANCE, PFO AND PAO | 03/19/2024 | 99,997 |
Muir Kevin | GM INTERVENTIONAL ONCOLOGY | 03/19/2024 | 50,001 |
Hoffman David L. | GEN'L COUNSEL, CCO & SECY | 03/19/2024 | 74,999 |
Vukovic Vojo | Chief Medical Officer | 12/12/2023 | 120,000 |
MICHEL GERARD J | Chief Executive Officer | 12/08/2023 | 99,960 |
Rosalind Advisors, Inc. | Director | 11/17/2023 | 240,410 |
Pennell Sandra | SVP of Finance, PFO and PAO | 11/17/2023 | 72,900 |
Vukovic Vojo | Chief Medical Officer | 11/16/2023 | 148,800 |
Hoffman David L. | See Remarks | 11/16/2023 | 99,200 |
Purpura John | Chief Operating Officer | 10/13/2023 | 49,897 |
Sylvester John Richard | Director | 08/21/2023 | 50,640 |
MICHEL GERARD J | Chief Executive Officer | 08/18/2023 | 139,995 |
MICHEL GERARD J | Chief Executive Officer | 03/29/2023 | 95,087 |
Rosalind Advisors, Inc. | Director | 12/14/2022 | 55,045 |
SALAMON STEVEN A J | Director | 12/14/2022 | 55,045 |
MICHEL GERARD J | Chief Executive Officer | 12/13/2022 | 150,003 |
MICHEL GERARD J | Chief Executive Officer | 07/20/2022 | 250,000 |
Purpura John | Chief Operating Officer | 05/16/2022 | 15,213 |
SALAMON STEVEN A J | Director | 05/13/2022 | 25,135 |
SALAMON STEVEN A J | Director | 05/12/2022 | 29,424 |
Rosalind Advisors, Inc. | Director | 04/19/2022 | 10,000 |
SALAMON STEVEN A J | Director | 04/19/2022 | 10,000 |
Rosalind Advisors, Inc. | Director | 04/18/2022 | 12,697 |
Aharon Gil | Director | 04/18/2022 | 12,697 |
MICHEL GERARD J | See Remarks | 04/18/2022 | 12,734 |
Rosalind Advisors, Inc. | Director | 04/13/2022 | 9,675 |
SALAMON STEVEN A J | Director | 04/13/2022 | 9,675 |
Rosalind Advisors, Inc. | Director | 04/12/2022 | 16,200 |
SALAMON STEVEN A J | Director | 04/12/2022 | 16,200 |
Purpura John | Chief Operating Officer | 04/11/2022 | 32,950 |
MICHEL GERARD J | See Remarks | 04/08/2022 | 13,136 |
SALAMON STEVEN A J | Director | 04/07/2022 | 6,410 |
SALAMON STEVEN A J | Director | 04/06/2022 | 6,490 |
Rosalind Advisors, Inc. | Director | 04/07/2022 | 6,410 |
Rosalind Advisors, Inc. | Director | 04/06/2022 | 6,490 |
Purpura John | Chief Operating Officer | 11/19/2020 | 20,288 |
SALAMON STEVEN A J | Director | 12/30/2021 | 15,120 |
Rosalind Advisors, Inc. | Director | 12/30/2021 | 15,120 |
MICHEL GERARD J | See Remarks | 12/02/2021 | 199,752 |
SALAMON STEVEN A J | Director | 06/30/2021 | 70,180 |
Rosalind Advisors, Inc. | Director | 06/30/2021 | 70,180 |
Rosalind Advisors, Inc. | Director | 06/28/2021 | 57,800 |
SALAMON STEVEN A J | Director | 06/28/2021 | 57,800 |
Rosalind Advisors, Inc. | Director | 06/28/2021 | 5,780,000 |
MICHEL GERARD J | Chief Executive Officer | 06/28/2021 | 74,563 |
MICHEL GERARD J | Chief Executive Officer | 06/25/2021 | 74,910 |
SALAMON STEVEN A J | Director | 06/24/2021 | 49,050 |
Purpura John | Chief Operating Officer | 05/13/2021 | 37,680 |
SALAMON STEVEN A J | Director | 03/31/2021 | 2,150,000 |
Rosalind Advisors, Inc. | Director | 03/31/2021 | 2,150,000 |
Aharon Gil | Director | 03/31/2021 | 2,150,000 |
MICHEL GERARD J | Chief Executive Officer | 12/11/2020 | 99,375 |
Purpura John | Chief Operating Officer | 11/19/2020 | 20,288 |
Rosalind Advisors, Inc. | Director | 11/17/2020 | 30,280 |
SALAMON STEVEN A J | Director | 11/17/2020 | 30,280 |
Rosalind Advisors, Inc. | Director | 11/13/2020 | 47,000 |
Aharon Gil | Director | 11/16/2020 | 24,000 |
SALAMON STEVEN A J | Director | 11/13/2020 | 23,020 |
Purpura John | EVP, Global Operations | 09/28/2018 | 9,625 |
STOLL ROGER G PHD | Director | 09/28/2018 | 8,575 |
Simpson Jennifer K. | President & CEO | 09/28/2018 | 12,948 |
Keck Barbra | Chief Financial Officer | 09/28/2018 | 12,948 |
Rueckert William Dodge | Director | 09/28/2018 | 11,375 |
STOLL ROGER G PHD | Director | 08/01/2018 | 2,466 |
Rueckert William Dodge | Director | 07/31/2018 | 8,103 |
Keck Barbra | Chief Financial Officer | 08/01/2018 | 239 |
Simpson Jennifer K. | President & CEO | 07/31/2018 | 255 |
Simpson Jennifer K. | President & CEO | 06/27/2017 | 102 |
Purpura John | EVP, Regulatory Affairs | 06/27/2017 | 50 |
Keck Barbra | Chief Financial Officer | 06/27/2017 | 37 |
Keck Barbra | Senior VP, Finance | 06/16/2016 | 2,140 |
Purpura John | EVP, Regulatory Affairs | 06/16/2016 | 2,935 |
Simpson Jennifer K. | President & CEO | 06/16/2016 | 6,001 |
STOLL ROGER G PHD | Director | 07/27/2015 | 10,740 |
Taglietti Marco | Director | 07/28/2015 | 54,433 |
Taglietti Marco | Director | 07/27/2015 | 52,350 |
Philips Laura A | Director | 07/23/2015 | 45,333 |
Philips Laura A | Director | 07/22/2015 | 35,376 |
Rueckert William Dodge | Director | 07/22/2015 | 9,580 |
LEUNG GABRIEL | Director | 06/15/2012 | 11,761 |
Philips Laura A | Director | 06/01/2012 | 98,049 |
WATSON DOUGLAS G | Director | 06/01/2012 | 75,275 |
Koplewicz Harold S | Director | 06/01/2012 | 99,454 |
Purpura John | EVP Reg. Affairs/Quality Assur | 06/01/2012 | 7,450 |
HOBBS EAMONN P | President and CEO | 06/01/2012 | 10,611 |
Simpson Jennifer K. | Exec. VP, Global Marketing | 06/01/2012 | 4,470 |
Miao Graham G | Exec. V.P., CFO | 05/31/2012 | 30,000 |
Kandarpa Krishna | Exec. V.P., Chief Medical Off. | 01/06/2012 | 129,790 |
LADD ROBERT | Director | 12/22/2011 | 24,421 |
LADD ROBERT | Director | 12/23/2011 | 24,660 |
LADD ROBERT | Director | 12/21/2011 | 20,000 |
LADD ROBERT | Director | 12/20/2011 | 19,500 |
LADD ROBERT | Director | 12/19/2011 | 19,185 |
LADD ROBERT | Director | 12/16/2011 | 19,614 |
LADD ROBERT | Director | 12/15/2011 | 20,114 |
LADD ROBERT | Director | 12/14/2011 | 20,900 |
LADD ROBERT | Director | 12/13/2011 | 22,800 |
LADD ROBERT | Director | 12/12/2011 | 23,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
VIVO CAPITAL, LLC | 855,191 | 0.29% | -53.9% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 169,602 | 0.00007% | 8.09% | Other |
BLACKROCK INC. | 91,932 | 0.00001% | 98.09% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View